The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Top Cited Papers
Open Access
- 1 June 2014
- journal article
- review article
- Published by Elsevier BV in Molecular Cell
- Vol. 54 (5), 728-736
- https://doi.org/10.1016/j.molcel.2014.05.016
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcriptionProceedings of the National Academy of Sciences of the United States of America, 2007
- Systematic Analysis of the Protein Interaction Network for the Human Transcription Machinery Reveals the Identity of the 7SK Capping EnzymeMolecular Cell, 2007
- The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional RegulationPublished by Elsevier BV ,2007
- Acetylation of GATA-1 is required for chromatin occupancyBlood, 2006
- Brd4 links chromatin targeting to HPV transcriptional silencingGenes & Development, 2006
- Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4Molecular Cell, 2005
- The Bromodomain Protein Brd4 Is a Positive Regulatory Component of P-TEFb and Stimulates RNA Polymerase II-Dependent TranscriptionMolecular Cell, 2005
- Locus control regions: coming of age at a decade plusTrends in Genetics, 1999
- Structure and ligand of a histone acetyltransferase bromodomainNature, 1999
- Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathwaysProceedings of the National Academy of Sciences of the United States of America, 1998